21 Invest France has acquired ProductLife Group with the company’s management team also investing significantly in the operation.
ProductLife Group is a specialist in regulatory affairs outsourced management and pharmacovigilance for the Healthcare and Life Sciences industries and more specifically for pharmaceutical laboratories. The group, created 25 years ago, benefits today from a solid and diversified base of more than 300 clients, of which 36 are in the World Top 50. It offers its services in more than 100 countries, notably through Global Outsourcing contracts.
ProductLife Group reaches circa EUR25 million in sales with strong profitability. Thanks to its clients’ trust and double-digit growth, company revenue is expected to double over the next years.
21 Invest is a European investment firm managing more than EUR1 billion on behalf of international investors, mainly institutional. Over the last 27 years, the group has completed over 100 investments supporting companies in their transformation and development project, alongside their management teams. This deal is the second of the new fund raised by the French team.
In order to meet its market expectations and with the support of 21 Invest France, ProductLife Group intends to further broaden its international coverage and accelerate its development through a strategy based on external growth, innovation and the launch of new service offers for related markets such as medical equipment.
Pierre Cuny, Executive Chairman of ProductLife Group, says: “We are happy to count on the support of a new reference shareholder as prestigious as 21 Invest. We trust it will actively support the group’s ambitious development plan to serve its customers. We would like to thank our historical shareholders for their invaluable support, unfailing trust and total loyalty over these last years. It’s a new momentum and a new era for ProductLife to better respond to the needs and requirements of its customers.”
Fabrice Voituron, Partner at 21 Invest France, says: “ProductLife is ideally positioned in a booming market. We are delighted to accompany the team in the realisation of its project combining resilience, strong growth and acquisition opportunities allowing ProductLife to reveal its full potential and become an undisputed leader on its market.”
Marc Lebrun, Associate Director at Adviso Partners, adds: “We were very pleased to advise the shareholders of ProductLife Group in this operation which enables to refocus the Group’s shareholding around the management team and its growth project, and also to provide the Group with a reference financial shareholder.”
